Wuhan Newforth Biotechnology Co., Ltd. is China's first ophthalmology gene drug research and development company, located in Wuhan Optics Valley Biological City, a state-level biological industrial park. Committed to the research and drug development of gene therapy for eye genetic diseases. Newforth first chose Leber hereditary optic neuropathy (LHON) as a breakthrough. Since 2008, a lot of basic research has been carried out...
Wuhan Newforth Biotechnology Co., Ltd. is China's first ophthalmology gene drug research and development company, located in Wuhan Optics Valley Biological City, a state-level biological industrial park. Committed to the research and drug development of gene therapy for eye genetic diseases. Newforth first chose Leber hereditary optic neuropathy (LHON) as a breakthrough. Since 2008, a lot of basic research has been carried out. In 2011, the world ’s first clinical study of gene therapy for Leber hereditary optic neuropathy was completed, and 9 patients participated in clinical research.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Wuhan National Bio-Industry Base Project B, C, D R & D Building B1, No. 666 Gaoxin Avenue, East Lake New Technology Development Zone, Wuhan Building 3rd Floor C270-C271